- Home
- EOSE vs ATRC Comparison
EOSE vs ATRC Comparison
Compare EOSE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- ATRC
- Stock Information
- Founded
- EOSE 2008
- ATRC 2000
- Country
- EOSE United States
- ATRC United States
- Employees
- EOSE N/A
- ATRC N/A
- Industry
- EOSE Industrial Machinery/Components
- ATRC Medical/Dental Instruments
- Sector
- EOSE Miscellaneous
- ATRC Health Care
- Exchange
- EOSE Nasdaq
- ATRC Nasdaq
- Market Cap
- EOSE 1.6B
- ATRC 1.6B
- IPO Year
- EOSE N/A
- ATRC 2005
- Fundamental
- Price
- EOSE $6.32
- ATRC $37.66
- Analyst Decision
- EOSE Strong Buy
- ATRC Strong Buy
- Analyst Count
- EOSE 3
- ATRC 10
- Target Price
- EOSE $6.50
- ATRC $49.60
- AVG Volume (30 Days)
- EOSE 12.6M
- ATRC 705.3K
- Earning Date
- EOSE 07-30-2025
- ATRC 07-29-2025
- Dividend Yield
- EOSE N/A
- ATRC N/A
- EPS Growth
- EOSE N/A
- ATRC N/A
- EPS
- EOSE N/A
- ATRC N/A
- Revenue
- EOSE $33,800,000.00
- ATRC $499,946,000.00
- Revenue This Year
- EOSE $945.82
- ATRC $14.63
- Revenue Next Year
- EOSE $195.86
- ATRC $12.62
- P/E Ratio
- EOSE N/A
- ATRC N/A
- Revenue Growth
- EOSE 128.49
- ATRC 16.28
- 52 Week Low
- EOSE $2.06
- ATRC $23.97
- 52 Week High
- EOSE $7.36
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- EOSE 56.22
- ATRC 64.88
- Support Level
- EOSE $5.77
- ATRC $34.91
- Resistance Level
- EOSE $6.40
- ATRC $36.20
- Average True Range (ATR)
- EOSE 0.39
- ATRC 1.15
- MACD
- EOSE -0.06
- ATRC 0.03
- Stochastic Oscillator
- EOSE 48.25
- ATRC 95.16
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.